31 – 40 of 81
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Leukemia associated mutant Wilms' tumor gene 1 protein promotes expansion of human hematopoietic progenitor cells.
2013) In Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis 37(10). p.1341-1349(
- Contribution to journal › Article
-
Mark
The radical-binding lipocalin A1M binds to a Complex I subunit and protects mitochondrial structure and function.
(
- Contribution to journal › Article
- 2012
-
Mark
The p53 target gene TRIM22 directly or indirectly interacts with the translation initiation factor eIF4E and inhibits the binding of eIF4E to eIF4G.
(
- Contribution to journal › Article
-
Mark
Tumor-initiating cells in childhood neuroblastoma : Letter
(
- Contribution to journal › Letter
- 2011
-
Mark
t(9;11)(p22;p15) [NUP98/PSIP1] is a poor prognostic marker associated with de novo acute myeloid leukaemia expressing both mature and immature surface antigens.
(
- Contribution to journal › Letter
-
Mark
Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
(
- Contribution to journal › Article
- 2010
-
Mark
Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies.
(
- Contribution to journal › Article
-
Mark
Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
(
- Contribution to journal › Article
-
Mark
Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study.
(
- Contribution to journal › Article
-
Mark
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.
(
- Contribution to journal › Article